The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multipeptide vaccine plus toll-like receptor agonists in melanoma patients, with evaluation of the vaccine site microenvironment and sentinel immunized node (Mel58; NCT01585350).
Craig L. Slingluff
Other Remuneration - UVA Patent Foundation
Gina R. Petroni
No relevant relationships to disclose
Kimberly A. Chianese-Bullock
No relevant relationships to disclose
William W. Grosh
No relevant relationships to disclose
Geoffrey R. Weiss
No relevant relationships to disclose